Cargando…
Eltrombopag for Adults and Children with Immune-Refractory Thrombocytopenic Purpura: A Systematic Review
Eltrombopag is an agonist that binds to the membrane-bound domain of the thrombopoietin receptor used in immune thrombocytopenic purpura (ITP). We conducted a meta-analysis of randomized controlled trials to assess the efficacy and safety of eltrombopag in adults and children with refractory ITP. Ad...
Autores principales: | de Barros Torelli, Danielle Francisco Honorato, Oliveira, Crystian Bitencourt Soares, Nai, Gisele Alborghetti, Trindade, Evelinda Marramon, Prestes-Carneiro, Luiz Euribel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299452/ https://www.ncbi.nlm.nih.gov/pubmed/37373566 http://dx.doi.org/10.3390/jcm12123872 |
Ejemplares similares
-
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
por: Rice, Lawrence
Publicado: (2009) -
Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab
por: Ahmed, Mohanad, et al.
Publicado: (2020) -
Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura
por: Uğur, Mehmet Can, et al.
Publicado: (2021) -
Eltrombopag-Induced Thrombocytosis and Thrombosis in Patients With Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura
por: Oo, Zayar, et al.
Publicado: (2022) -
Use of Eltrombopag for the First Trimester Pregnancy Complicated with Refractory Idiopathic Thrombocytopenic Purpura: A Case Report and Literature Review
por: Shibata, Satoshi, et al.
Publicado: (2022)